Department of Otolaryngology - Head and Neck Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
Department of Head and Neck Surgery, University of California, Los Angeles David Geffen School of Medicine, Los Angeles, California, USA.
Int Forum Allergy Rhinol. 2022 Sep;12(9):1131-1136. doi: 10.1002/alr.22970. Epub 2022 Apr 8.
Topical steroids are a mainstay in the treatment of chronic rhinosinusitis (CRS). Multiple delivery methods of topical steroids following sinus surgery have been investigated. The purpose of this trial is to evaluate the effect of triamcinolone-impregnated absorbable nasal packing on healing following endoscopic sinus surgery (ESS).
This is a prospective, randomized, double-blind, placebo-controlled trial. A total of 22 subjects (14 without polyps and eight with polyps) were enrolled and were randomized to receive triamcinolone-impregnated packing in one sinus cavity and normal saline-soaked packing in the contralateral sinus cavity. Endoscopic evaluation was completed at the first two postoperative visits, and Lund-Kennedy (LK) endoscopic scores and perioperative sinus endoscopy (POSE) scores were calculated at each visit.
The results of this study found no significant difference in the appearance of the sinuses at either postoperative visit. Mean LK scores for the triamcinolone and saline groups at the first and second postoperative visits were 2.09 ± 1.23 versus 2.18 ± 1.01 (p = 0.79) and 1.79 ± 1.08 versus 1.68 ± 1.16 (p = 0.77), respectively. POSE scores were 2.59 ± 1.71 versus 2.68 ± 1.62 (p = 0.86) and 1.74 ± 1.15 versus 1.95 ± 1.22 (p = 0.59).
The results of this study demonstrated no significant difference in healing, crusting, polyps, edema, or secretions between the triamcinolone-treated and non-triamcinolone-treated sinuses. There were no adverse effects from the use of triamcinolone-impregnated absorbable packing. Further studies will be necessary to determine the impact of triamcinolone-impregnated absorbable packing following ESS.
局部皮质类固醇是治疗慢性鼻-鼻窦炎(CRS)的主要方法。已经研究了鼻窦手术后局部皮质类固醇的多种给药方法。本试验的目的是评估曲安奈德浸渍可吸收鼻腔填塞对内镜鼻窦手术(ESS)后愈合的影响。
这是一项前瞻性、随机、双盲、安慰剂对照试验。共纳入 22 例受试者(14 例无息肉和 8 例有息肉),并随机分为单侧鼻窦腔接受曲安奈德浸渍填塞,对侧鼻窦腔接受生理盐水浸泡填塞。术后前两次就诊时进行内镜评估,并在每次就诊时计算 Lund-Kennedy(LK)内镜评分和围手术期鼻窦内镜(POSE)评分。
本研究结果发现,术后两次就诊时鼻窦外观均无显著差异。曲安奈德组和生理盐水组术后第 1 天和第 2 天的平均 LK 评分分别为 2.09±1.23 与 2.18±1.01(p=0.79)和 1.79±1.08 与 1.68±1.16(p=0.77)。POSE 评分分别为 2.59±1.71 与 2.68±1.62(p=0.86)和 1.74±1.15 与 1.95±1.22(p=0.59)。
本研究结果表明,曲安奈德治疗组与非曲安奈德治疗组的愈合、结痂、息肉、水肿或分泌物无显著差异。曲安奈德浸渍可吸收填塞无不良反应。需要进一步研究以确定 ESS 后曲安奈德浸渍可吸收填塞的影响。